Clinical Trial Update: Reverse Triple Negative Immune Resistant Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating reversal of immune-resistant triple-negative breast cancer; currently recruiting at Fudan University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Triple-negative Breast Cancer | Phase 2 | Status: RECRUITING